by European Public Health Alliance | Apr 14, 2016 | Opinion
Convened by the UN Secretary General 16 world personalities review and assess proposals and recommend solutions to close the gap between inventors, international human rights law, trade rules and public health in the context of health technologies. Are EU officials...
by European Public Health Alliance | Mar 2, 2016 | Opinion
In February, trade negotiators from the EU and the US met in Brussels for the twelfth round of negotiations on the Transatlantic Trade and Investment Partnership (TTIP) – behind closed doors. Among other things, they discussed an EU proposal on regulatory...
by European Public Health Alliance | Mar 2, 2016 | Opinion
by Yannis Natsis Policy Coordinator Universal access and affordable medicines, EPHA Since the start of the Juncker Commission, we are witnessing an awkward new reality. There is no major new health-related legislation heading for the European Parliament, and nothing...
by European Public Health Alliance | Feb 1, 2016 | Opinion
The Dutch Presidency appears to be keeping its cards close to its chest as far as pharmaceuticals and public health are concerned. So far, they seem to have been purposefully ambiguous about their intentions and have not put forward any concrete proposals on the...
by European Public Health Alliance | Feb 1, 2016 | Opinion
“The astronomical and immorally high prices of medicines in Greece and internationally create a situation of social cannibalism, as patients are forced to compete for the treatments they need”. This is the situation according to Yannis Natsis, Policy Coordinator on...
